Qube Research & Technologies LTD Procept Bio Robotics Corp Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 36,051 shares of PRCT stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,051Holding current value
$3.51 Million% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
240Shares Held
37.5MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$459 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$339 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$176 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$170 Million0.07% of portfolio
-
Loomis Sayles & CO L P1.26MShares$123 Million0.11% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.34B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...